RAPT Therapeutics, Inc.

JPMORGAN CHASE & CO RAPT

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/12/2025

Shares

108,328

Value ($000)

132

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/12/2025	132	0.0%	108,328	3/31/2025
2024 Q4	2/12/2025	324	0.0%	205,164	12/31/2024
2024 Q3	11/8/2024	34	0.0%	16,703	9/30/2024
2024 Q2	8/12/2024	51	0.0%	16,573	6/30/2024
2024 Q1	5/10/2024	175	0.0%	19,446	3/31/2024
2023 Q4	2/12/2024	652	0.0%	26,234	12/31/2023
2023 Q3	11/14/2023	439	0.0%	26,397	9/30/2023
2023 Q2	8/11/2023	457	0.0%	24,413	6/30/2023
2023 Q1	5/18/2023	451	0.0%	24,589	3/31/2023
2022 Q4	2/13/2023	326	0.0%	16,486	12/31/2022
2022 Q3	11/14/2022	395	0.0%	16,415	9/30/2022
2022 Q2	8/11/2022	283	0.0%	15,469	6/30/2022
2022 Q1	5/11/2022	299	0.0%	13,575	3/31/2022
2021 Q4	2/11/2022	403	0.0%	10,976	12/31/2021
2021 Q3	11/12/2021	561	0.0%	18,082	9/30/2021
2021 Q2	8/12/2021	259	0.0%	8,159	6/30/2021
2021 Q1	5/12/2021	93	0.0%	4,182	3/31/2021
2020 Q4	2/19/2021	251	0.0%	12,700	12/31/2020
2020 Q3	11/12/2020	226	0.0%	8,234	9/30/2020
2020 Q2	8/11/2020	830	0.0%	28,595	6/30/2020
2020 Q1	5/12/2020	11	0.0%	499	3/31/2020
2019 Q4	2/11/2020	14	0.0%	507	12/31/2019